Transepithelial transport characteristics of Hydroxysafflor yellow A across cellular monolayers and the effects of the influx and efflux transporters

被引:2
作者
Tang, Dongyun [1 ,2 ]
Ye, Taiwei [1 ]
Chen, Xiuping [3 ]
Yang, Jun [2 ]
Xie, Yan [1 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Res Ctr Hlth & Nutr, Shanghai 201203, Peoples R China
[2] Shanghai Huangpu Dist Xiangshan Hosp Tradit Chines, Pharm Dept, Shanghai 200020, Peoples R China
[3] Shanghai Univ Tradit Chinese Med, Innovat Res Inst Tradit Chinese Med, Shanghai 201203, Peoples R China
基金
上海市自然科学基金; 中国国家自然科学基金;
关键词
Hydroxysafflor yellow A; Intestinal permeability; Transport mechanism; Transporters; Cell monolayers; Caco-2; cells; ARISTOLOCHIC ACID I; INTESTINAL PERMEABILITY; P-GLYCOPROTEIN; DRUG-PERMEABILITY; CACO-2; CELLS; VITRO; ABSORPTION; VIVO; MODELS; RATS;
D O I
10.1016/j.fbio.2023.103037
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Hydroxysafflor yellow A (HSYA), the major biologically active constituent distributed in the florets of Carthamus tinctorius L. (safflower), is concerned with potential health-promoting functions against cardiovascular diseases. However, little information on clarifying the intestinal absorption characteristics of HSYA has been reported, which has limited its widespread application in the medical and healthcare fields. The intention of this research was to systematically characterize the transepithelial transport of HSYA using in vitro cell monolayer models (Caco-2, mucus-producing Caco-2/HT29-MTX-E12, MDCKII and P-gp overexpressed MDCKII-MDR1 cell mono layers). The apparent permeability coefficient (Papp) from the apical to the basolateral side of HSYA is approximately (4.30 & PLUSMN; 0.22) x 10-8 cm/s, suggesting that HSYA is poorly absorbed across the intestinal epithelium. The transport and uptake of HSYA depends on time, concentration, pH and temperature, and the Papp values increase with ethylene diamine tetraacetic acid pretreatment, indicating that the transport mechanisms of HSYA include passive diffusion (transcellular and paracellular pathways) and carrier-mediated transport. Meanwhile, transporter inhibitors were added in transport and uptake experiments, the results showed that carrier-mediated efflux and influx transport of HSYA is relevant to P-glycoprotein and H+ correlative transporters (e.g., peptide transporter 1, monocarboxylic acid transporter). In addition, the mucus layer acts as a barrier to HSYA absorption, as evidenced by a decrease in Papp (22-47%) and cellular uptake (18%) in the coculture model compared to the Caco-2 cell model. Detailed knowledge on the transepithelial transport of HSYA would provide insights to improve the pharmacological activities of HSYA and expand its application in food and healthcare fields.
引用
收藏
页数:10
相关论文
共 68 条
[1]   Nonionic surfactants increase digoxin absorption in Caco-2 and MDCKII MDR1 cells: Impact on P-glycoprotein inhibition, barrier function, and repeated cellular exposure [J].
Al-Ali, Ahmed A. Abdulhussein ;
Steffansen, Bente ;
Holm, Rene ;
Nielsen, Carsten Uhd .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 551 (1-2) :270-280
[2]   Hydroxysafflor Yellow A: A Promising Therapeutic Agent for a Broad Spectrum of Diseases [J].
Ao, Hui ;
Feng, Wuwen ;
Peng, Cheng .
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2018, 2018
[3]   CORRELATION BETWEEN ORAL-DRUG ABSORPTION IN HUMANS AND APPARENT DRUG PERMEABILITY COEFFICIENTS IN HUMAN INTESTINAL EPITHELIAL (CACO-2) CELLS [J].
ARTURSSON, P ;
KARLSSON, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 175 (03) :880-885
[4]  
ARTURSSON P, 1991, CRIT REV THER DRUG, V8, P305
[5]   Caco-2 monolayers in experimental and theoretical predictions of drug transport (Reprinted from Advanced Drug Delivery Reviews, vol 22, pg 67-84, 1996) [J].
Artursson, P ;
Palm, K ;
Luthman, K .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 46 (1-3) :27-43
[6]   Property profiling of biosimilar mucus in a novel mucus-containing in vitro model for assessment of intestinal drug absorption [J].
Boegh, Marie ;
Baldursdottir, Stefania G. ;
Mullertz, Anette ;
Nielsen, Hanne M. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2014, 87 (02) :227-235
[7]  
Chen YF, 2019, FOOD FUNCT, V10, P5215, DOI [10.1039/c9fo01007f, 10.1039/C9FO01007F]
[8]  
Delshad Elahe, 2018, Electron Physician, V10, P6672, DOI 10.19082/6672
[9]   Intestinal drug transporters in pathological states: an overview [J].
Drozdzik, Marek ;
Czekawy, Izabela ;
Oswald, Stefan ;
Drozdzik, Agnieszka .
PHARMACOLOGICAL REPORTS, 2020, 72 (05) :1173-1194
[10]   Solid lipid nanocarriers diffuse effectively through mucus and enter intestinal cells - but where is my peptide? [J].
Dumont, Camille ;
Beloqui, Ana ;
Miolane, Cedric ;
Bourgeois, Sandrine ;
Preat, Veronique ;
Fessi, Hatem ;
Jannin, Vincent .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2020, 586